Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' DEFICIT (Tables)

v3.24.1.1.u2
SHAREHOLDERS' DEFICIT (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of stock options activity

Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Number of

Exercise

Remaining

Aggregate

Shares Subject

Price Per

Contractual

Intrinsic Value

to Options

Share

Life (in years)

(in thousands)

Balance at December 31, 2022

 

49,040

$

129.60

 

2.8

 

  

Options granted

 

10,000

$

0.86

Options canceled

 

(22,615)

$

130.82

Balance at December 31, 2023

 

36,425

$

93.55

3.5

Options expired

(5,370)

$

156.00

Options canceled

 

(10,000)

$

0.86

Balance at March 31, 2024

 

21,055

$

121.65

 

2.0

 

$

Vested and exercisable at March 31, 2024

 

20,265

$

121.81

 

1.9

 

$

Schedule of stock options outstanding and exercisable

Options Outstanding

Options Exercisable

    

Weighted

    

    

    

Average

Weighted

Weighted

Remaining

Average

Average

Number of

Contractual

Exercise Price

Number

Exercise Price

Outstanding

Life (in years)

Per Share

Exercisable

Per Share

2,475

 

0.5

$

128.00

 

2,475

$

128.00

9,830

1.8

$

106.00

9,830

$

106.00

1,500

2.0

$

112.00

1,300

$

112.00

5,750

2.5

$

153.00

5,560

$

153.00

1,500

2.9

$

103.20

1,100

$

103.20

21,055

 

2.0

$

121.65

 

20,265

$

121.81

Schedule of warrants

    

Number of Warrants outstanding

Convertible debt, warrants issued

 

8,645

Debenture, warrants issued

13,750

Other warrants issued

9,000

December 2020 equity financing warrants issued

163,579

Total warrant outstanding

 

194,974